These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 24608078

  • 1. Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement.
    Wu SY, McCavit TL, Cederberg K, Galindo RL, Leavey PJ.
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):402-5. PubMed ID: 24608078
    [Abstract] [Full Text] [Related]

  • 2. Infantile myofibromatosis.
    Larralde M, Ferrari B, Martinez JP, Barbieri MAF, Méndez JH, Casas J.
    An Bras Dermatol; 2017 Jul; 92(6):854-857. PubMed ID: 29364448
    [Abstract] [Full Text] [Related]

  • 3. Diverse presentation and tailored treatment of infantile myofibromatosis: A single-center experience.
    Manisterski M, Benish M, Levin D, Shiran SI, Sher O, Gortzak Y, Elhasid R.
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28769. PubMed ID: 33063933
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
    Gandhi MM, Nathan PC, Weitzman S, Levitt GA.
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):750-4. PubMed ID: 12972815
    [Abstract] [Full Text] [Related]

  • 5. Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy.
    Gehle S, Quinsey C, McShane D, Thompson P, Quezada G.
    J Pediatr Hematol Oncol; 2023 Oct 01; 45(7):e921-e923. PubMed ID: 37526359
    [Abstract] [Full Text] [Related]

  • 6. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
    Bidadi B, Watson A, Weigel B, Oliveira A, Kirkham J, Arndt C.
    Pediatr Blood Cancer; 2020 Jun 01; 67(6):e28288. PubMed ID: 32307894
    [Abstract] [Full Text] [Related]

  • 7. Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis.
    Proust S, Benchimol G, Fraitag S, Starck J, Giacobbi V, Pierron G, Bodemer C, Orbach D.
    Pediatr Blood Cancer; 2021 Jan 01; 68(1):e28576. PubMed ID: 32896962
    [No Abstract] [Full Text] [Related]

  • 8. First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate.
    Azzam R, Abboud M, Muwakkit S, Khoury N, Saab R.
    Pediatr Blood Cancer; 2009 Feb 01; 52(2):308. PubMed ID: 18937326
    [No Abstract] [Full Text] [Related]

  • 9. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
    Mudry P, Slaby O, Neradil J, Soukalova J, Melicharkova K, Rohleder O, Jezova M, Seehofnerova A, Michu E, Veselska R, Sterba J.
    BMC Cancer; 2017 Feb 10; 17(1):119. PubMed ID: 28183292
    [Abstract] [Full Text] [Related]

  • 10. Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options.
    Weaver MS, Navid F, Huppmann A, Meany H, Angiolillo A.
    J Pediatr Hematol Oncol; 2015 Apr 10; 37(3):237-41. PubMed ID: 25389917
    [Abstract] [Full Text] [Related]

  • 11. Infantile myofibromatosis: a case report and review of the literature.
    Ang P, Tay YK, Walford NQ.
    Cutis; 2004 Apr 10; 73(4):229-31. PubMed ID: 15134320
    [Abstract] [Full Text] [Related]

  • 12. Infantile myofibromatosis.
    Ariffin H, Teh KH, Looi LM, Ariffin WA, Lin HP.
    Med J Malaysia; 2001 Dec 10; 56(4):497-9. PubMed ID: 12014771
    [Abstract] [Full Text] [Related]

  • 13. Brief report: successful therapy of a patient with infantile generalized myofibromatosis.
    Day M, Edwards AO, Weinberg A, Leavey PJ.
    Med Pediatr Oncol; 2002 May 10; 38(5):371-3. PubMed ID: 11979466
    [No Abstract] [Full Text] [Related]

  • 14. Infantile myofibromatosis: a series of 28 cases.
    Mashiah J, Hadj-Rabia S, Dompmartin A, Harroche A, Laloum-Grynberg E, Wolter M, Amoric JC, Hamel-Teillac D, Guero S, Fraitag S, Bodemer C.
    J Am Acad Dermatol; 2014 Aug 10; 71(2):264-70. PubMed ID: 24894456
    [Abstract] [Full Text] [Related]

  • 15. Infantile myofibromatosis: report on a family with autosomal dominant inheritance and variable penetrance.
    Kulkarni K, Desai S, Grundy P, Sergi C.
    J Pediatr Surg; 2012 Dec 10; 47(12):2312-5. PubMed ID: 23217896
    [Abstract] [Full Text] [Related]

  • 16. Morphologic Overlap between Infantile Myofibromatosis and Infantile Fibrosarcoma: A Pitfall in Diagnosis.
    Alaggio R, Barisani D, Ninfo V, Rosolen A, Coffin CM.
    Pediatr Dev Pathol; 2008 Dec 10; 11(5):355-62. PubMed ID: 19006426
    [Abstract] [Full Text] [Related]

  • 17. Congenital myofibromatosis in two siblings.
    Arcangeli F, Calista D.
    Eur J Dermatol; 2006 Dec 10; 16(2):181-3. PubMed ID: 16581573
    [Abstract] [Full Text] [Related]

  • 18. Multicentric infantile myofibromatosis: two perinatal cases.
    Pelluard-Nehmé F, Coatleven F, Carles D, Alberti EM, Briex M, Dallay D.
    Eur J Pediatr; 2007 Oct 10; 166(10):997-1001. PubMed ID: 17186271
    [Abstract] [Full Text] [Related]

  • 19. Recurrent infantile myofibromatosis: a report of conservative management and discussion of treatment strategies.
    Ebert CS, Zdanski C, Ardeshirpour F, Patel M, Hart CF, Drake AF.
    Ear Nose Throat J; 2008 Dec 10; 87(12):E4. PubMed ID: 19105133
    [Abstract] [Full Text] [Related]

  • 20. Generalized infantile myofibromatosis with a monophasic primitive pattern.
    Iwafuchi H, Tsuzuki T, Ito R, Miyake H, Okita H, Hamazaki M.
    Pathol Int; 2015 Aug 10; 65(8):432-7. PubMed ID: 25989870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.